JP2000095790A - Novel palladium-imidazole complex - Google Patents

Novel palladium-imidazole complex

Info

Publication number
JP2000095790A
JP2000095790A JP10269859A JP26985998A JP2000095790A JP 2000095790 A JP2000095790 A JP 2000095790A JP 10269859 A JP10269859 A JP 10269859A JP 26985998 A JP26985998 A JP 26985998A JP 2000095790 A JP2000095790 A JP 2000095790A
Authority
JP
Japan
Prior art keywords
compound
complex
palladium
reaction
catalyst
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10269859A
Other languages
Japanese (ja)
Other versions
JP3624304B2 (en
Inventor
Shoji Satake
彰治 佐竹
Tadashi Nakada
忠 中田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIKEN Institute of Physical and Chemical Research
Original Assignee
RIKEN Institute of Physical and Chemical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIKEN Institute of Physical and Chemical Research filed Critical RIKEN Institute of Physical and Chemical Research
Priority to JP26985998A priority Critical patent/JP3624304B2/en
Publication of JP2000095790A publication Critical patent/JP2000095790A/en
Application granted granted Critical
Publication of JP3624304B2 publication Critical patent/JP3624304B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a novel palladium-imidazole complex that has no bad smell and no toxicity and is useful as a ligand for palladium complex having excellent stability and high catalytic activity. SOLUTION: This novel compound is represented by the formula [R1 and R2 are each H, a lower alkyl; R3 is a (substituted)2-pyridinyl]. This compound can be prepared by the process described in a literature (Synthesis, 489, 1980, Hughey IV, J.L., et al). This novel compound is mixed with a palladium compound, for example, allylpalladium chloride in an inert solvent for example, dichloromethane or the like to give a palladium complex, which is useful for organic synthetic reactions for example, cyclopropanation reaction or the like.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は新規なパラジウム−
イミダゾール錯体、及び該錯体を含む有機合成用触媒に
関するものである。
TECHNICAL FIELD The present invention relates to a novel palladium
The present invention relates to an imidazole complex and a catalyst for organic synthesis containing the complex.

【0002】[0002]

【従来の技術】パラジウム触媒は、炭素−炭素結合形成
反応、酸化反応、還元反応など様々な有機合成反応にお
いて有用であり、従来、主としてパラジウム−リンやパ
ラジウム−ひ素型の触媒として用いられている。しかし
ながら、これらの触媒は活性が高いものの、酸化されや
すいために活性を失いやすいという問題があり、また、
配位子であるリンやひ素には悪臭や毒性があることか
ら、環境汚染などの問題を引き起こす場合があった。従
って、リンやヒ素に替わる配位子を有するパラジム触媒
の開発が求められている。
2. Description of the Related Art A palladium catalyst is useful in various organic synthesis reactions such as a carbon-carbon bond forming reaction, an oxidation reaction, and a reduction reaction, and has been conventionally mainly used as a palladium-phosphorus or palladium-arsenic type catalyst. . However, although these catalysts have high activity, they have a problem that they are easily oxidized and thus easily lose their activity.
Since the ligands phosphorus and arsenic have a bad smell and toxicity, they may cause problems such as environmental pollution. Therefore, there is a need for the development of a palladium catalyst having a ligand replacing phosphorus and arsenic.

【0003】[0003]

【発明が解決しようとする課題】本発明の課題は、リン
やヒ素に替えて悪臭や毒性のない配位子を有し、安定性
と触媒活性に優れたパラジム錯体を提供することにあ
る。また、本発明の別の課題は、上記の特徴を有するパ
ラジム錯体を触媒として用いる有機合成反応を提供する
ことにある。
An object of the present invention is to provide a palladium complex which has a non-odorous or nontoxic ligand in place of phosphorus or arsenic and has excellent stability and catalytic activity. Another object of the present invention is to provide an organic synthesis reaction using a palladium complex having the above characteristics as a catalyst.

【0004】[0004]

【課題を解決するための手段】本発明者らは上記の課題
を解決すべく鋭意研究を行ってきたが、パラジウム−ピ
リジニルピラゾール錯体が上記の特徴を有する触媒とし
て有用であり、各種の有機合成反応において高い触媒活
性を有することを見出した(特願平10-113493号)。本
発明者らは上記の課題を解決すべくさらに研究を行い、
下記の式(I)で表されるイミダゾール化合物を配位子と
して含むパラジウム錯体が上記の特徴を有しており、該
錯体がシクロプロパン化反応などの有機合成反応におい
て優れた触媒活性と選択性を発揮できることを見出し
た。本発明はこれらの知見を基にして完成されたもので
ある。
The present inventors have intensively studied to solve the above-mentioned problems, but palladium-pyridinylpyrazole complex is useful as a catalyst having the above-mentioned characteristics, They have found that they have high catalytic activity in organic synthesis reactions (Japanese Patent Application No. 10-113493). The present inventors conducted further research to solve the above problems,
A palladium complex containing an imidazole compound represented by the following formula (I) as a ligand has the above characteristics, and the complex has excellent catalytic activity and selectivity in an organic synthesis reaction such as a cyclopropanation reaction. Was found to be able to demonstrate. The present invention has been completed based on these findings.

【0005】すなわち本発明は、下記の一般式(I):That is, the present invention provides the following general formula (I):

【化2】 (式中、R1及びR2はそれぞれ独立に水素原子又は低級ア
ルキル基を示し、R3は置換又は無置換の2-ピリジニル基
を示す)で表されるパラジウム金属用の配位子;及び該
配位子を含むパラジウム錯体が提供される。また、該錯
体を含む有機合成用触媒、好ましくは炭素−炭素結合用
触媒、さらに好ましくはシクロプロパン形成用触媒が提
供される。本発明の触媒は、例えば、ケテンシリルアセ
タールを用いるシクロプロパン化反応において触媒活性
を有する。別の観点からは、本発明により、上記触媒を
用いたシクロプロパン化反応が提供される。
Embedded image (Wherein, R 1 and R 2 each independently represent a hydrogen atom or a lower alkyl group, and R 3 represents a substituted or unsubstituted 2-pyridinyl group) a ligand for palladium metal; A palladium complex comprising the ligand is provided. Further, a catalyst for organic synthesis containing the complex, preferably a catalyst for carbon-carbon bond, more preferably a catalyst for forming cyclopropane is provided. The catalyst of the present invention has catalytic activity in, for example, a cyclopropanation reaction using ketene silyl acetal. In another aspect, the present invention provides a cyclopropanation reaction using the above catalyst.

【0006】[0006]

【発明の実施の形態】上記一般式(I)において、R1及びR
2はそれぞれ独立に水素原子又は低級アルキル基を示
す。R1及びR2が同時に水素原子であることが好ましい
が、R1及びR2のいずれか、又は両者が低級アルキル基で
あってもよい。両者が低級アルキル基である場合にはそ
れらは同一でも異なっていてもよい。低級アルキル基と
しては、炭素原子数1〜12個、好ましくは1〜6個程
度の直鎖、分枝鎖、若しくは環状のアルキル基、又はこ
れらの組み合わせであるアルキル基を用いることができ
る。環状アルキル基の環上には1個又は2個以上の直鎖
又は分枝鎖の低級アルキル基が置換していてもよい。よ
り具体的には、低級アルキル基として、メチル基、エチ
ル基、n-プロピル基、イソプロピル基、シクロプロピル
基、n-ブチル基、sec-ブチル基、tert-ブチル基、シク
ロブチル基、シクロプロピルメチル基などを用いること
ができる。
BEST MODE FOR CARRYING OUT THE INVENTION In the above general formula (I), R 1 and R
2 each independently represents a hydrogen atom or a lower alkyl group. It is preferred that R 1 and R 2 are simultaneously hydrogen atoms, but either or both of R 1 and R 2 may be lower alkyl groups. When both are lower alkyl groups, they may be the same or different. As the lower alkyl group, a linear, branched or cyclic alkyl group having 1 to 12 carbon atoms, preferably about 1 to 6 carbon atoms, or an alkyl group which is a combination thereof can be used. One or more linear or branched lower alkyl groups may be substituted on the ring of the cyclic alkyl group. More specifically, as a lower alkyl group, methyl group, ethyl group, n-propyl group, isopropyl group, cyclopropyl group, n-butyl group, sec-butyl group, tert-butyl group, cyclobutyl group, cyclopropylmethyl Groups can be used.

【0007】R3は置換又は無置換の2-ピリジニル基を示
す。2-ピリジニル基が置換基を有する場合、環上の置換
基の個数、種類、及び置換位置は特に限定されないが、
本発明のパラジウム錯体を有機合成用の触媒として用い
る場合には、目的の反応における触媒活性を高めるよう
に、当該反応において不活性な置換基のなかから適宜選
択することが望ましい。置換基として、例えば、低級ア
ルキル基、低級アルコキシ基(メトキシ基、エトキシ基
など)、ハロゲン原子(フッ素原子、塩素原子、臭素原
子など)などを用いることができる。置換位置として
は、6-位が好ましい。R3としては無置換の2-ピリジニル
基又は6-低級アルキル-2-ピリジニル基が好ましく、無
置換の2-ピリジニル基又は6-メチル-2-ピリジニル基が
特に好ましい。
R 3 represents a substituted or unsubstituted 2-pyridinyl group. When the 2-pyridinyl group has a substituent, the number, type, and position of the substituent on the ring are not particularly limited,
When the palladium complex of the present invention is used as a catalyst for organic synthesis, it is desirable to appropriately select from the substituents that are inert in the reaction so as to enhance the catalytic activity in the target reaction. As the substituent, for example, a lower alkyl group, a lower alkoxy group (such as a methoxy group or an ethoxy group), a halogen atom (such as a fluorine atom, a chlorine atom, or a bromine atom) can be used. The substitution position is preferably at the 6-position. R 3 is preferably an unsubstituted 2-pyridinyl group or a 6-lower alkyl-2-pyridinyl group, and particularly preferably an unsubstituted 2-pyridinyl group or 6-methyl-2-pyridinyl group.

【0008】上記の式(I)で表される化合物には互変異
性体が存在しており、上記化合物は下記の実施例に示し
たようにパラジウム金属に配位して、本発明のパラジウ
ム錯体を形成していると考えられる(下記の式におい
て、R3が無置換の2-ピリジル基である化合物を示し
た)。もっとも、本発明の配位子をこれらの互変異性体
のいずれかに限定して解釈してはならない。
[0008] The compound represented by the above formula (I) has tautomers, and the compound is coordinated to palladium metal as shown in the following Examples to form the palladium of the present invention. It is considered to form a complex (in the following formula, a compound in which R 3 is an unsubstituted 2-pyridyl group is shown). However, the ligand of the present invention should not be interpreted as being limited to any of these tautomers.

【化3】 Embedded image

【0009】上記の式(I)で表される化合物の一部は公
知であり、文献記載の方法に従って製造することができ
る(J. L. Hughey IV, S. Knapp, H. Schugar, Synthes
is, 489, 1980)。上記刊行物記載の方法に準じて、原
料化合物、反応試薬、反応条件などを適宜選択すること
により、またその方法に適宜の修飾ないしは改変を加え
ることにより、上記式(I)に包含される化合物をいずれ
も製造することが可能である。
Some of the compounds represented by the above formula (I) are known and can be produced according to the methods described in the literature (JL Hughey IV, S. Knapp, H. Schugar, Synthes).
is, 489, 1980). According to the methods described in the above-mentioned publications, by appropriately selecting starting compounds, reaction reagents, reaction conditions, and the like, and by appropriately modifying or modifying the method, a compound included in the above formula (I) Can be manufactured.

【0010】上記式(I)に包含される代表的化合物とし
て、化合物Ia(R1及びR2が水素原子であり、R3が無置換
2-ピリジニル基である化合物)及び化合物Ib(R1及びR2
が水素原子であり、R3が6-メチル-2-ピリジニル基であ
る化合物)を挙げることができる。これらの化合物は室
温下では無臭の固体であり、空気中でも安定である。
As a typical compound included in the above formula (I), compound Ia (R 1 and R 2 are hydrogen atoms and R 3 is unsubstituted)
A compound which is a 2-pyridinyl group) and a compound Ib (R 1 and R 2
Is a hydrogen atom, and R 3 is a 6-methyl-2-pyridinyl group). These compounds are odorless solids at room temperature and are stable in air.

【0011】上記式(I)で表される化合物とパラジウム
化合物(例えば塩化アリルパラジウムなど)を不活性溶
媒中で混合することにより、本発明のパラジウム錯体を
製造することができる。本発明のパラジウム錯体は、通
常、上記式(I)で表される化合物のほかに1個の配位子
を有しているが、この配位子の種類は特に限定されな
い。また、本発明のパラジウム錯体が塩を形成する場合
には、アニオンの種類は特に限定されず、いかなる形態
の塩も本発明の錯体に包含される。
The palladium complex of the present invention can be produced by mixing the compound represented by the above formula (I) and a palladium compound (for example, allyl palladium chloride) in an inert solvent. The palladium complex of the present invention usually has one ligand in addition to the compound represented by the above formula (I), but the kind of the ligand is not particularly limited. When the palladium complex of the present invention forms a salt, the type of anion is not particularly limited, and any form of salt is included in the complex of the present invention.

【0012】例えば、上記化合物1a又は化合物Ibと塩化
アリルパラジウムとをAgBF4の存在下に反応させること
によりテトラフルオロボレートの形態のパラジウム錯体
(錯体2a又は2b)が得られる。テトラフルオロボレート
の形態の錯体(カチオン型)は、さらに塩基で処理する
ことによって中性型の錯体3a又は3bに変換することがで
きる。このようなカチオン型及び中性型の錯体はいずれ
も本発明の範囲に包含される。
For example, a palladium complex in the form of tetrafluoroborate (complex 2a or 2b) is obtained by reacting the above-mentioned compound 1a or compound Ib with allyl palladium chloride in the presence of AgBF 4 . The complex in the form of tetrafluoroborate (cationic) can be converted into the neutral complex 3a or 3b by further treatment with a base. Both such cationic and neutral complexes are included within the scope of the present invention.

【0013】[0013]

【化4】 Embedded image

【0014】本発明の錯体は各種の有機合成用触媒とし
て利用することができる。本発明の錯体は、中性錯体の
形態で種々の有機溶媒に対して高い溶解性を示すので、
各種の有機反応において幅広い反応条件を適用すること
が可能である。本発明の錯体を触媒として用いる場合の
有機反応は特に限定されないが、例えば、炭素−炭素結
合形成反応、酸化反応、又は還元反応などに用いること
が可能である。本発明の錯体を用いて行われる特徴的な
炭素−炭素結合形成反応として、シクロプロパン環の形
成反応を挙げることができる。
The complex of the present invention can be used as various organic synthesis catalysts. Since the complex of the present invention exhibits high solubility in various organic solvents in the form of a neutral complex,
A wide range of reaction conditions can be applied in various organic reactions. The organic reaction in the case where the complex of the present invention is used as a catalyst is not particularly limited. For example, the organic reaction can be used for a carbon-carbon bond forming reaction, an oxidation reaction, a reduction reaction, or the like. As a characteristic carbon-carbon bond forming reaction performed using the complex of the present invention, a reaction for forming a cyclopropane ring can be exemplified.

【0015】本明細書の実施例に具体的に示したよう
に、本発明のパラジウム錯体2a又は2bは、エステル誘導
体であるケテンシリルアセタ−ルと酢酸アリルとの反応
において触媒活性を示し、シクロプロパン化合物を主生
成物として与える。本発明の方法に利用可能なケテンシ
リルアセタールの構造は特に限定されず、当業者は適宜
の化合物を選択することができる。代表的なケテンシリ
ルアセタールを本明細書の実施例に具体的に示した。ま
た、酢酸シンナミルとの反応では立体選択的に反応が進
行し、トランスの配置を持つシクロプロパンが得られ
る。本発明のパラジウム錯体を触媒として用いる場合の
使用量は特に限定されず、有機反応の種類や反応条件に
応じて適宜選択可能であるが、例えば、0.01〜100 mol%
程度の濃度で使用することができる。なお、溶媒の種
類、反応条件、試薬の種類などは当業者に適宜選択可能
であることはいうまでもない。
As specifically shown in the examples of the present specification, the palladium complex 2a or 2b of the present invention exhibits catalytic activity in the reaction of the ester derivative ketene silyl acetal with allyl acetate, The cyclopropane compound is given as the main product. The structure of ketene silyl acetal that can be used in the method of the present invention is not particularly limited, and those skilled in the art can select an appropriate compound. Representative ketene silyl acetals are illustrated in the examples herein. In the reaction with cinnamyl acetate, the reaction proceeds stereoselectively, and cyclopropane having a trans configuration is obtained. The amount used when the palladium complex of the present invention is used as a catalyst is not particularly limited and can be appropriately selected depending on the type of organic reaction and reaction conditions, for example, 0.01 to 100 mol%.
It can be used at a moderate concentration. Needless to say, the type of solvent, reaction conditions, type of reagent, and the like can be appropriately selected by those skilled in the art.

【0016】[0016]

【実施例】以下、実施例により本発明をさらに具体的に
説明するが、本発明の範囲はこれらの実施例に限定され
ることはない。実施例中の化合物番号は上記スキーム中
の化合物番号に対応している。 例1:化合物1bの製造 文献(Hughey IV, J.L., et al., Synthesis, 489, 198
0)に記載された化合物1aの製造に準じて、原料化合物
として3-メチル-2-シアノピリジンを用いて56%の収率で
化合物1bを得た。1 H NMR (300 MHz, CDCl3) δ 11.1 (br, 1H), 8.37 (b
r.d, 1H, J = 4.8 Hz), 7.59 (br.d, 1H, J = 7.6 Hz),
7.30 (s, 1H), 7.15 (m, 1H), 7.11 (s, 1H), 2.85
(s, 3H).13 C NMR (75 MHz, CDCl3) δ 147.2, 146.21, 145.93,
139.87, 131.79, 130.31, 122.56, 116.45, 20.88. mp 121℃ Anal. Found: C, 67.72; H, 5.69; N, 26.19%. Calcd.
for C, 67.91; H, 5.70;N, 26.40%.
The present invention will be described in more detail with reference to the following examples, but the scope of the present invention is not limited to these examples. The compound numbers in the examples correspond to the compound numbers in the above scheme. Example 1: Preparation of compound 1b Literature (Hughey IV, JL, et al., Synthesis, 489, 198)
According to the production of compound 1a described in 0), compound 1b was obtained in a yield of 56% using 3-methyl-2-cyanopyridine as a starting compound. 1 H NMR (300 MHz, CDCl 3 ) δ 11.1 (br, 1H), 8.37 (b
rd, 1H, J = 4.8 Hz), 7.59 (br.d, 1H, J = 7.6 Hz),
7.30 (s, 1H), 7.15 (m, 1H), 7.11 (s, 1H), 2.85
(s, 3H). 13 C NMR (75 MHz, CDCl 3 ) δ 147.2, 146.21, 145.93,
139.87, 131.79, 130.31, 122.56, 116.45, 20.88.mp 121 ° C Anal.Found: C, 67.72; H, 5.69; N, 26.19% .Calcd.
for C, 67.91; H, 5.70; N, 26.40%.

【0017】例2:パラジウム錯体(錯体2)の製造 100 mL褐色三口フラスコに AgBF4 (278 mg, 1.428 mmo
l) とη3-allylpalladiumchloride dimer (261 mg, 0.7
14 mmol) を入れ、反応系をアルゴン置換した後、0℃に
冷やしてジクロルメタン40 mL を加えた。反応混合物を
10分撹拌した後、細かく砕いた化合物1a (208 mg, 1.42
8 mmol) を固体のままを加えた。反応混合物を0℃で5
分撹拌した後、室温に戻してさらに1時間撹拌した。反
応容器にメタノール40 mLを加えて不溶固体をセライト
ろ過し、ろ液を減圧下で濃縮し、残渣を乾燥して錯体2a
を得た (515 mg, 収率95%)。
Example 2 Production of Palladium Complex (Complex 2) AgBF 4 (278 mg, 1.428 mmo) was placed in a 100 mL brown three-necked flask.
l) and η 3 -allylpalladiumchloride dimer (261 mg, 0.7
14 mmol), the reaction system was purged with argon, cooled to 0 ° C., and 40 mL of dichloromethane was added. The reaction mixture
After stirring for 10 minutes, compound 1a (208 mg, 1.42
(8 mmol) was added as a solid. The reaction mixture is allowed to
After stirring for minutes, the mixture was returned to room temperature and further stirred for 1 hour. 40 mL of methanol was added to the reaction vessel, the insoluble solid was filtered through celite, the filtrate was concentrated under reduced pressure, and the residue was dried to obtain complex 2a.
Was obtained (515 mg, yield 95%).

【0018】1H NMR (600 MHz, CD3OD : CD2Cl2 = 1:1)
δ 8.75 (br.d, 1H, J = 5.4 Hz), 8.19 (ddd, 1H, J
= 7.8, 7.8, 1.5 Hz), 8.08 (br.d, 1H, J = 7.8 Hz),
7.60 (ddd, 1H, J = 7.8, 5.4, 1.5 Hz), 7.43 (d, 1H,
J = 1.0 Hz), 7.31 (d, 1H, J= 1.0 Hz), 5.85 (tt, 1
H, J = 12.7, 6.3 Hz), 4.41 (br, 1H), 4.35 (br, 1
H), 3.48 (br, 1H), 3.30 (br, 1H).13 C NMR (150 MHz, CD3OD : CD2Cl2 = 1 : 1) δ 15
4.98, 148.45, 147.91, 141.63, 131.45, 127.09, 121.
86, 121.29, 118.46, 63.60, 58.31. mp 220℃ (decomp.) Anal Calcd. for C11H12N3PdBF4 : C, 34.82; H, 3.19;
N, 11.07; Found: C, 34.52; H, 3.11; N, 10.79.
1 H NMR (600 MHz, CD 3 OD: CD 2 Cl 2 = 1: 1)
δ 8.75 (br.d, 1H, J = 5.4 Hz), 8.19 (ddd, 1H, J
= 7.8, 7.8, 1.5 Hz), 8.08 (br.d, 1H, J = 7.8 Hz),
7.60 (ddd, 1H, J = 7.8, 5.4, 1.5 Hz), 7.43 (d, 1H,
J = 1.0 Hz), 7.31 (d, 1H, J = 1.0 Hz), 5.85 (tt, 1
H, J = 12.7, 6.3 Hz), 4.41 (br, 1H), 4.35 (br, 1
. H), 3.48 (br, 1H), 3.30 (br, 1H) 13 C NMR (150 MHz, CD 3 OD: CD 2 Cl 2 = 1: 1) δ 15
4.98, 148.45, 147.91, 141.63, 131.45, 127.09, 121.
86, 121.29, 118.46, 63.60, 58.31.mp 220 ° C (decomp.) Anal Calcd. For C 11 H 12 N 3 PdBF 4 : C, 34.82; H, 3.19;
N, 11.07; Found: C, 34.52; H, 3.11; N, 10.79.

【0019】同様にして、化合物1b (233 mg) から錯体
2bを得た (565 mg, 収率83%)。1 H NMR (300 MHz, DMSO-d6) δ 13.10 (br), 8.75 (br.
d, J = 5.1 Hz), 8.10 (br.d, J = 7.7 Hz), 7.71 (br.
s), 7.57 (dd, J = 7.7, 5.1 Hz), 7.54 (br.s),5.90
(tt, J = 12.1, 6.6 Hz), 4.39 (syn 2H, d, J = 6.6 H
z), 3.36 (anti 2H, d, J = 12.1 Hz), 2.69 (Me, br.
s).13 C NMR (150 MHz, DMSO-d6) δ 152.53, 146.36, 144.
98, 143.14, 132.32, 130.42, 125.94, 122.51, 118.0
4, 60.81, 19.66
Similarly, a complex was prepared from compound 1b (233 mg).
2b was obtained (565 mg, 83% yield). 1 H NMR (300 MHz, DMSO-d 6 ) δ 13.10 (br), 8.75 (br.
d, J = 5.1 Hz), 8.10 (br.d, J = 7.7 Hz), 7.71 (br.
s), 7.57 (dd, J = 7.7, 5.1 Hz), 7.54 (br.s), 5.90
(tt, J = 12.1, 6.6 Hz), 4.39 (syn 2H, d, J = 6.6 H
z), 3.36 (anti 2H, d, J = 12.1 Hz), 2.69 (Me, br.
s). 13 C NMR (150 MHz, DMSO-d 6) δ 152.53, 146.36, 144.
98, 143.14, 132.32, 130.42, 125.94, 122.51, 118.0
4, 60.81, 19.66

【0020】例3:パラジウム錯体(錯体3)の製造 錯体2aをNaHCO3水溶液中で攪拌後、ジクロロメタンで抽
出し、抽出液を無水MgSO 4で乾燥後に濃縮して錯体3aを
得た。1 H NMR (600 MHz, CD3OD : CD2Cl2 = 1 : 1) δ 8.46
(br.d, 1H, J = 5.4 Hz),7.93 (br.d, 1H, J = 8.3 H
z), 7.88 (ddd, 1H, J = 8.3, 8.3, 1.5 Hz), 7.18(dd
d, 1H, J = 8.3, 5.4, 1.0 Hz), 7.14 (br.s, 1H), 7.1
0 (br.s, 1H), 5.67(tt, 1H, J = 12.7, 6.8 Hz), 4.13
(d, 1H, J = 6.8 Hz), 4.03 (d, 1H, J =6.8 Hz), 3.2
6 (d, 1H, J = 12.7 Hz), 3.03 (d, 1H, J = 12.7 Hz).13 C NMR (150 MHz, CD3OD : CD2Cl2 = 1 : 1) δ 154.7
6, 153.97, 153.51, 140.15, 130.99, 130.81, 122.92,
119.94, 116.47, 61.68, 54.38.
EXAMPLE 3 Preparation of Palladium Complex (Complex 3)ThreeAfter stirring in an aqueous solution, extract with dichloromethane.
And extract was dried over anhydrous MgSO FourAfter drying with, the complex 3a is concentrated.
Obtained.1 H NMR (600 MHz, CDThreeOD: CDTwoClTwo = 1: 1) δ 8.46
(br.d, 1H, J = 5.4 Hz), 7.93 (br.d, 1H, J = 8.3 H
z), 7.88 (ddd, 1H, J = 8.3, 8.3, 1.5 Hz), 7.18 (dd
d, 1H, J = 8.3, 5.4, 1.0 Hz), 7.14 (br.s, 1H), 7.1
0 (br.s, 1H), 5.67 (tt, 1H, J = 12.7, 6.8 Hz), 4.13
 (d, 1H, J = 6.8 Hz), 4.03 (d, 1H, J = 6.8 Hz), 3.2
6 (d, 1H, J = 12.7 Hz), 3.03 (d, 1H, J = 12.7 Hz).13 C NMR (150 MHz, CDThreeOD: CDTwoClTwo = 1: 1) δ 154.7
6, 153.97, 153.51, 140.15, 130.99, 130.81, 122.92,
 119.94, 116.47, 61.68, 54.38.

【0021】同様にして錯体2b (202 mg) から錯体3bを
得た (147 mg, 収率94%)。1 H NMR (300 MHz, DMSO-d6) δ 8.49 (d, J = 5.4 Hz),
7.81 (d, J = 7.8 Hz),7.15 (dd, J = 7.8, 5.4 Hz),
7.09 (s), 7.08 (s), 5.72 (m), 4.05 (syn 2H,br), 3.
28 (anti 1H, br), 2.96 (anti 1H, br), 2.76 (Me,
s).13 C NMR (150 MHz, DMSO-d6) δ 154.63, 151.16, 150.
55, 141.68, 130.79, 130.61, 129.64, 121.18, 115.9
0, 62.00, 53.22, 19.84. mp 138℃ Anal Calcd. for C12H13N3Pd : C, 47.16; H, 4.29; N,
13.75; Pd, 34.81 Found: C, 47.17; H, 4.22; N, 1
3.71; Pd, 34.79.
Similarly, complex 3b was obtained from complex 2b (202 mg) (147 mg, 94% yield). 1 H NMR (300 MHz, DMSO-d 6 ) δ 8.49 (d, J = 5.4 Hz),
7.81 (d, J = 7.8 Hz), 7.15 (dd, J = 7.8, 5.4 Hz),
7.09 (s), 7.08 (s), 5.72 (m), 4.05 (syn 2H, br), 3.
28 (anti 1H, br), 2.96 (anti 1H, br), 2.76 (Me,
s). 13 C NMR (150 MHz, DMSO-d 6 ) δ 154.63, 151.16, 150.
55, 141.68, 130.79, 130.61, 129.64, 121.18, 115.9
0, 62.00, 53.22, 19.84.mp 138 ° C Anal Calcd. For C 12 H 13 N 3 Pd: C, 47.16; H, 4.29; N,
13.75; Pd, 34.81 Found: C, 47.17; H, 4.22; N, 1
3.71; Pd, 34.79.

【0022】例4:シクロプロパン化反応Example 4: Cyclopropanation reaction

【化5】 Embedded image

【0023】25 mL 枝付なすフラスコに本発明のパラジ
ウム錯体2a(19 mg, 0.05 mmol)と酢酸ナトリウム(1
6.4 mg, 0.2 mmol)を加え、反応系をアルゴン置換した
後、DMSO 2 mL を加えた。反応混合物を5分間撹拌した
後、酢酸アリル(100 mg, 1 mmol)をDMSO 1 mLに溶解
して加えた。続いて、ケテンアセタール(429 mg, 2 mm
ol)をDMSO 1 mLに溶かして加え、室温で撹拌を継続し
たところ、反応液は無色からうすい黄色に変化した。反
応経過をガスクロマトグラフィーで追跡し、化合物6a及
び7aの生成が止まった時点で反応を終了した(室温で90
分撹拌後Pd黒の沈殿が生じ、反応が終了した)。
The palladium complex 2a (19 mg, 0.05 mmol) of the present invention and sodium acetate (1
6.4 mg, 0.2 mmol), and the reaction system was purged with argon, and then 2 mL of DMSO was added. After stirring the reaction mixture for 5 minutes, allyl acetate (100 mg, 1 mmol) dissolved in 1 mL of DMSO was added. Next, ketene acetal (429 mg, 2 mm
ol) was dissolved in 1 mL of DMSO and added, and stirring was continued at room temperature. As a result, the reaction solution changed from colorless to pale yellow. The progress of the reaction was monitored by gas chromatography, and the reaction was terminated when the formation of compounds 6a and 7a was stopped (90 ° C at room temperature).
After stirring for a minute, Pd black precipitate was formed, and the reaction was completed).

【0024】反応溶液に、エーテル5 mLと水5 mLを加
え、続いて10% HCl 水溶液を3 mL 加えて室温で30分撹
拌し、残っているケテンアセタールを加水分解した。有
機層をエーテルで抽出し、飽和NaHCO3水溶液と飽和食塩
水で洗浄した。有機層を乾燥し(MgSO4)、ろ過した
後、ろ液を減圧下で濃縮した。得られた油状物質のうち
比較的低沸点のものは蒸留によって除去し、残査をエー
テル−ヘキサン(1:9)溶媒を用い、シリカゲルクロ
マトグラフィーによって精製すると、化合物6a及び化合
物7aの混合物が得られた。生成物の混合比をガスクロマ
トグラフィーおよびNMRを用いて算出したところ、化合
物6a:化合物7aの生成比は23:1であった。純粋な化合物
6aは特願平10-113493号明細書の実施例に記載の方法で
単離した。同様にしてパラジウム錯体2bを用いた場合の
化合物6aと化合物7aの生成比は44:1であった。
To the reaction solution, 5 mL of ether and 5 mL of water were added, followed by 3 mL of a 10% aqueous HCl solution, and the mixture was stirred at room temperature for 30 minutes to hydrolyze the remaining ketene acetal. The organic layer was extracted with ether, and washed with a saturated aqueous solution of NaHCO 3 and a saturated saline solution. The organic layer was dried (MgSO 4 ), filtered, and the filtrate was concentrated under reduced pressure. The oily substance having a relatively low boiling point was removed by distillation, and the residue was purified by silica gel chromatography using an ether-hexane (1: 9) solvent to obtain a mixture of compound 6a and compound 7a. Was done. When the mixture ratio of the products was calculated by using gas chromatography and NMR, the formation ratio of compound 6a: compound 7a was 23: 1. Pure compound
6a was isolated by the method described in the example of Japanese Patent Application No. 10-113493. Similarly, when palladium complex 2b was used, the formation ratio of compound 6a to compound 7a was 44: 1.

【0025】例5:シクロプロパン化反応 上記の例4と同様にして、触媒2a又は2bを用いて、化合
物6b及び化合物7bを製造した。
Example 5: Cyclopropanation reaction Compound 6b and compound 7b were produced in the same manner as in Example 4 above, using catalyst 2a or 2b.

【化6】 Embedded image

【0026】化合物6b1 H NMR (500MHz, CDCl3) δ 4.08 (q, 2H), 1.21 (t, 3
H), 1.01 (s, 3H), 1.00(m, 1H), 0.35-0.22 (m, 4H).13 C NMR (125.8 MHz, CDCl3), δ 177.9, 60.2, 41.1,
22.9, 19.5, 14.5, 0.70. MS, m/z (relative intensity) 156 (M+, 3.3), 141 (1
7.5), 128 (6.6), 113 (9.9), 110 (10.4), 100 (24.
8), 83 (100), 67 (11.6), 55 (99.3).
Compound 6b 1 H NMR (500 MHz, CDCl 3 ) δ 4.08 (q, 2H), 1.21 (t, 3
H), 1.01 (s, 3H ), 1.00 (m, 1H), 0.35-0.22 (m, 4H). 13 C NMR (125.8 MHz, CDCl 3), δ 177.9, 60.2, 41.1,
22.9, 19.5, 14.5, 0.70.MS, m / z (relative intensity) 156 (M + , 3.3), 141 (1
7.5), 128 (6.6), 113 (9.9), 110 (10.4), 100 (24.
8), 83 (100), 67 (11.6), 55 (99.3).

【0027】また、同様に触媒2a又は2bを用いて、化合
物6c及び化合物7cを製造した。
Similarly, Compound 6c and Compound 7c were produced using Catalyst 2a or 2b.

【化7】 Embedded image

【0028】化合物6c1 H NMR (500MHz, CDCl3) δ 7.29 (t, 2H), 7.18 (t, 1
H), 7.13 (d, 2H), 4.17(m, 2H), 1.99 (s, 3H), 1.93
(ddd, 1H, J=5.0, 5.7, 9.2 Hz), 1.39 (ddd, 1H, J-5.
0, 5.7, 8.7 Hz), 1.26 (t, 3H, J=7.1 Hz), 1.20 (s,
3H), 1.01 (ddd,1H, J=5.5, 5.7, 8.7 Hz), 0.90 (ddd,
1H, J=5.5, 5.7, 9.2 Hz).13 C NMR (125.8 MHz, CDCl3) δ 177.3, 143.0, 128.2,
126.1, 125.4, 60.4, 41.5, 31.1, 23.2 (2C), 19.1,
14.2, 11.3. Anal. Found: C, 77.27; H, 8.85%. Calcd for C15H20O
2 : C, 77.55; H, 8.69%.
Compound 6c 1 H NMR (500 MHz, CDCl 3 ) δ 7.29 (t, 2H), 7.18 (t, 1
H), 7.13 (d, 2H), 4.17 (m, 2H), 1.99 (s, 3H), 1.93
(ddd, 1H, J = 5.0, 5.7, 9.2 Hz), 1.39 (ddd, 1H, J-5.
0, 5.7, 8.7 Hz), 1.26 (t, 3H, J = 7.1 Hz), 1.20 (s,
3H), 1.01 (ddd, 1H, J = 5.5, 5.7, 8.7 Hz), 0.90 (ddd,
1H, J = 5.5, 5.7, 9.2 Hz). 13 C NMR (125.8 MHz, CDCl 3) δ 177.3, 143.0, 128.2,
126.1, 125.4, 60.4, 41.5, 31.1, 23.2 (2C), 19.1,
14.2, 11.3. Anal.Found: C, 77.27; H, 8.85% .Calcd for C 15 H 20 O
2 : C, 77.55; H, 8.69%.

【0029】[0029]

【発明の効果】本発明のパラジウム錯体は安定であり、
配位子としてリンやヒ素を含む錯体に比べて悪臭などの
問題が回避されているので取り扱いに便利である。ま
た、シクロプロパン化反応など多様な有機反応用触媒と
して利用することができ、特にシクロプロパン化反応に
おいて優れた選択性を有する触媒として有用である。
The palladium complex of the present invention is stable,
It is convenient to handle since problems such as bad smell are avoided as compared with complexes containing phosphorus or arsenic as a ligand. Further, it can be used as a catalyst for various organic reactions such as cyclopropanation reaction, and is particularly useful as a catalyst having excellent selectivity in cyclopropanation reaction.

フロントページの続き Fターム(参考) 4C063 AA01 BB01 CC25 DD12 EE10 4G069 AA15 BA27A BA27B BC72A BC72B BE13A BE38A BE38B CB65 4H050 AA01 AA03 AB40 WB14 WB21Continued on the front page F term (reference) 4C063 AA01 BB01 CC25 DD12 EE10 4G069 AA15 BA27A BA27B BC72A BC72B BE13A BE38A BE38B CB65 4H050 AA01 AA03 AB40 WB14 WB21

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 下記の一般式(I): 【化1】 (式中、R1及びR2はそれぞれ独立に水素原子又は低級ア
ルキル基を示し、R3は置換又は無置換の2-ピリジニル基
を示す)で表されるパラジウム金属用の配位子。
1. The following general formula (I): (Wherein, R 1 and R 2 each independently represent a hydrogen atom or a lower alkyl group, and R 3 represents a substituted or unsubstituted 2-pyridinyl group).
【請求項2】 請求項1に記載の一般式(I)で表される
配位子を含むパラジウム錯体。
2. A palladium complex containing the ligand represented by the general formula (I) according to claim 1.
【請求項3】 R1及びR2が水素原子であり、R3が無置換
2-ピリジニル基又は6-メチル-2-ピリジニル基である請
求項2に記載のパラジウム錯体。
3. R 1 and R 2 are hydrogen atoms, and R 3 is unsubstituted
The palladium complex according to claim 2, which is a 2-pyridinyl group or a 6-methyl-2-pyridinyl group.
【請求項4】 請求項2又は3に記載のパラジウム錯体
を含む有機合成用触媒。
4. A catalyst for organic synthesis comprising the palladium complex according to claim 2 or 3.
【請求項5】 シクロプロパン化反応に用いる請求項4
に記載の触媒。
5. The method according to claim 4, which is used in a cyclopropanation reaction.
The catalyst according to the above.
【請求項6】 ケテンシリルアセタールを用いるシクロ
プロパン化反応において触媒活性を有する請求項5に記
載の触媒。
6. The catalyst according to claim 5, which has catalytic activity in a cyclopropanation reaction using ketene silyl acetal.
JP26985998A 1998-09-24 1998-09-24 Novel palladium-imidazole complex Expired - Fee Related JP3624304B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP26985998A JP3624304B2 (en) 1998-09-24 1998-09-24 Novel palladium-imidazole complex

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26985998A JP3624304B2 (en) 1998-09-24 1998-09-24 Novel palladium-imidazole complex

Publications (2)

Publication Number Publication Date
JP2000095790A true JP2000095790A (en) 2000-04-04
JP3624304B2 JP3624304B2 (en) 2005-03-02

Family

ID=17478205

Family Applications (1)

Application Number Title Priority Date Filing Date
JP26985998A Expired - Fee Related JP3624304B2 (en) 1998-09-24 1998-09-24 Novel palladium-imidazole complex

Country Status (1)

Country Link
JP (1) JP3624304B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007222780A (en) * 2006-02-23 2007-09-06 Kobe Univ Imidazole compound-palladium complex catalyst and method of producing aromatic olefin compound using the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007222780A (en) * 2006-02-23 2007-09-06 Kobe Univ Imidazole compound-palladium complex catalyst and method of producing aromatic olefin compound using the same

Also Published As

Publication number Publication date
JP3624304B2 (en) 2005-03-02

Similar Documents

Publication Publication Date Title
EP0916637B1 (en) Process for preparating optically active compounds
CN109988117B (en) Preparation method of 3-methylquinoxaline-2 (1H) -ketone derivatives
EP1910253A2 (en) Stable cyclic (alkyl)(amino) carbenes as ligands for transition metal catalysts
CN110105305B (en) Transition metal catalyzed C-H activation/cyclization synthesis 1,2-benzothiazine derivative green synthesis method
JP3878703B2 (en) Chiral ruthenium complex, process for its preparation, and process for enantioselective transfer hydrogenation of prochiral ketones
CN105772094A (en) Chiral nitrogen heterocycle carbene type catalyst and application thereof
US5457219A (en) Phosphorus compounds
JP3526310B2 (en) Asymmetric reduction method
JPH0920762A (en) Chiral manganese/triazanonane complexes and their production
US5648548A (en) Optically active asymmetric diphosphine and process for producing optically active substance in its presence
US6462200B2 (en) Diphosphines
JP3624304B2 (en) Novel palladium-imidazole complex
US5523437A (en) Tertiary phosphine compound and transition metal complex comprising the same as ligand
CN110143962B (en) Novel method for synthesizing benzimidazole [1,2-a ] quinoline derivative
JP4416466B2 (en) Method for producing benzene derivatives
JP2004537405A (en) Palladium catalyst
JP4413507B2 (en) Pincer metal complex, method for producing the same, and pincer metal complex catalyst
JP3624302B2 (en) Novel palladium-pyridinylpyrazole complex
CN112209947A (en) Chiral indoxazinone compound and synthesis method thereof
CN111499648A (en) Axial chiral bidentate ligand, catalyst, preparation method and application thereof
JPH1072430A (en) Production of optically active sulfoxide compound
JP3399507B2 (en) New palladium-oxazoline pyrazole complex
JP2004196710A (en) Ligand and asymmetric catalyst
CN113735867B (en) Chiral indolo oxa seven-membered ring compound and synthesis method thereof
CN113999207B (en) Pyridyl-containing chiral NNN tridentate ligand, asymmetric catalytic hydrogenation synthesis thereof and application of pyridyl-containing chiral NNN tridentate ligand in asymmetric catalytic reaction

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20031201

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20040415

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040811

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041008

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20041102

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20041116

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees